BRCA1 and metabolic dysfunction-associated steatotic liver disease: Future studies can make use of high-throughput sequencing technology, gene editing tools such as CRISPR-Cas9, and bioinformatics analyses to explore in depth the mechanism of BRCA1’s role in MASLD.